MedTrace Logo

Study of RRS® HA Long Lasting for Improving Facial Wrinkles and Skin Quality

NCT07551609 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2026-05-22

No results posted yet for this study

Summary

The objective of this clinical study is to confirm the clinical performance and long-term safety of the CE-marked RRS® HA Long Lasting in the treatment of skin photoaging and its consequences, with a primary focus on improving facial wrinkles and skin quality in healthy adults.

The main questions it aims to answer are: the proportion of responders achieving a clinically significant change in facial wrinkles from baseline to Month 2 on both sides of the face; improvement in photodamage compared to the control group at 2 months. Researchers will compare the group treated with RRS® HA Long Lasting to an untreated control group to evaluate the product's effectiveness in improving facial wrinkles and skin quality.

Conditions

  • Photoaged Facial Skin
  • Photoaging
  • Wrinkle Reduction
  • Skin Quality Improvement

Interventions

DEVICE

RRS® HA Long Lasting

RRS® HA Long Lasting is a sterile medical device, Class III, dermal implant that contains cross-linked, resorbable Hyaluronic acid (HA).

Sponsors & Collaborators

  • Skin Tech Pharma Group S.L.U.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-20
Primary Completion
2027-03-30
Completion
2028-03-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07551609 on ClinicalTrials.gov